RESUMEN
Antithyroid drugs have been reported to reduce the expression of HLA-DR in thyrocytes in Graves' disease, but only circumstantial evidence has been provided about their in vivo immunologic effects. This present study was designed to examine the in vivo immunologic effect of antithyroid drugs on thyroid follicular cells. The study was conducted on 25 patients who had Graves' disease in remission or in activity and who were or were not receiving treatment (7 in overt thyrotoxicosis, 6 patients in remission, and 12 patients under medication). HLA-DR expression in thyroid biopsies was verified by immunohistochemistry. The follicular cells of all patients in overt thyrotoxicosis expressed HLA-DR whereas those of patients in remission were negative for HLA-DR. HLA-DR was also not expressed in all patients under medication, but this did not correlate with the clinical evolution after thyroid drug withdrawal. In conclusion, antithyroid drugs inhibit follicular cell HLA-DR expression in Graves' disease, when thyrotoxicosis is controlled. This suggests that additional mechanisms not involving HLA-DR play a role in thyroid autoimmune disease.
Asunto(s)
Antitiroideos/uso terapéutico , Enfermedad de Graves/tratamiento farmacológico , Enfermedad de Graves/inmunología , Antígenos HLA-DR/metabolismo , Glándula Tiroides/inmunología , Adulto , Biopsia con Aguja , Femenino , Enfermedad de Graves/patología , Humanos , Inmunohistoquímica , Masculino , Glándula Tiroides/patología , Distribución TisularRESUMEN
CONTEXT: Surface HLA-DR antigen is usually only expressed by antigen-presenting cells (APC). In autoimmune thyroid disease, follicle cells function as APC, thus expressing HLA-DR. However, non-autoimmune thyroid diseases may also express surface class II antigens. OBJECTIVE: To evaluate the presence and pattern of HLA class II expression in autoimmune and non-autoimmune thyroid disorders. DESIGN: Retrospective: histopathological and immunohistochemical analysis. LOCATION: Referral center, university hospital. SAMPLE: Ten histologically normal thyroids, 11 Graves' disease, 7 Hashimoto's thyroiditis, 10 atoxic multinodular goiter and 3 toxic adenomas were analyzed by immunohistochemistry, using a monoclonal antibody anti-HLA-DR. MAIN MEASUREMENTS: The presence of these antigens in thyroid follicular cells and their relation to inflammatory infiltrate was evaluated. The pattern of HLA-DR expression in thyroid follicular cells was analyzed: membrane, cytoplasmic or both. RESULTS: Although HLA-DR antigens were sparsely present in one of the 8 normal thyroids, in 6 of the 9 atoxic multinodular goiter and in 2 of the 3 toxic adenomas a net positivity could be seen in large areas. In all 5 Hashimoto's thyroiditis and in 7 of the 10 Graves' disease cases. This expression occurred in follicle cells either in contact with inflammatory cells or not. In non-autoimmune thyroid disease, HLA-DR positivity was essentially cytoplasmic, whereas in Graves' disease and Hashimoto thyroiditis it was mainly in cell membranes. CONCLUSIONS: It is suggested that the HLA class II expression on the surface of follicle cells could be related to auto-antigen presentation to the immune system by these cells, leading to inflammation.
Asunto(s)
Enfermedades Autoinmunes/inmunología , Antígenos HLA-DR/análisis , Enfermedades de la Tiroides/inmunología , Anticuerpos Monoclonales/análisis , Enfermedades Autoinmunes/patología , Enfermedad de Graves/inmunología , Enfermedad de Graves/fisiopatología , Humanos , Técnicas para Inmunoenzimas , Estudios Retrospectivos , Enfermedades de la Tiroides/patología , Tiroiditis Autoinmune/inmunología , Tiroiditis Autoinmune/patologíaAsunto(s)
Estradiol/sangre , Infertilidad Femenina/diagnóstico , Progesterona/sangre , Frotis Vaginal , Adolescente , Adulto , Endometrio/patología , Femenino , HumanosRESUMEN
A case of diffuse and bilateral necrosis of the renal medulla in an infant aged 2-1/2 months is reported. The possible causes of such severe lesion are discussed. Gastroenteritis, hypotensive state and use of a nephrotoxic drug (gentamicin) are considered to be important pathogenetical factors acting simultaneously in this patient.